NOT:ETR
Novartis AG
126,90 €
arrow_downward
-0,36%(-0,46) 1D
30-сен., 17:35:34 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Open
128,48 €
High
129,42 €
Low
126,68 €
Mkt. cap
288,77 млд
Avg. vol.
6,00 миң
Volume
3,76 миң
52-wk high
144,12 €
52-wk low
104,52 €
No. of employees
75 миң
Open
128,48 €
High
129,42 €
Low
126,68 €
Mkt. cap
288,77 млд
Avg. vol.
6,00 миң
Volume
3,76 миң
52-wk high
144,12 €
52-wk low
104,52 €
No. of employees
75 миң
News stories
From web sources and news partners
AD HOC NEWS
·
10 саат мурун
Novartis stock trades at EUR 128.19 with minus 0.07 percent
GuruFocus
·
19 саат мурун
Novartis AG (NVS) Shares Fall 0.8% -- What GF Score of 78 Tells Investors
Yahoo Finance
·
1 күн мурун
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
BioSpace
·
1 күн мурун
3 steps for taking on Novartis in radiopharma: Curium up first
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 миң
Founded1996-ж., 7-мар.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websitenovartis.com